Brian Jensen, MD, associate professor of medicine and pharmacology, and colleagues identified for the first-time mechanisms underlying the cardiotoxicity of kinase inhibitors used to treat cancer.
Brian Jensen, MD, associate professor of medicine and pharmacology, and colleagues identified for the first-time mechanisms underlying the cardiotoxicity of kinase inhibitors used to treat cancer.